Chinese Nationalist Party (KMT) lawmakers yesterday accused Democratic Progressive Party (DPP) presidential candidate Tsai Ing-wen (蔡英文) of a conflict of interest because of her involvement with a biotech start-up after leaving office that received investment from the state-owned National Development Fund. They demanded that documents relating to the investment be made public immediately.
According to fund data, on Feb. 15, 2007 then-Council for Economic Planning and Development chairperson and NDF convener Ho Mei-yueh (何美玥) sent documents labeled classified to then-premier Su Tseng-chang (蘇貞昌) and then-vice premier Tsai for approval, stating that under certain conditions, the fund would invest US$20 million in a company that would work with US firm Genentech.
The committee managing the fund passed an incidental motion on April 17 that it would retain the Feb. 15 document for future reference, the fund’s data showed.
On Aug. 31 the same year, Tsai sent a letter to the fund asking it to wire NT$40 million to the account of the “Taimao Protein Technology Co Preparatory Office (台懋蛋白胜科技股份有限公司)” before Sept. 3. Another letter was sent on the same day saying the company’s name had been changed to “Yu Chang Biologics Co (宇昌生技股份有限公司),” repeating the request for the fund to wire NT$40 million to the account of Yu Chang Biologics Co Preparatory Office.
Yu Chang Biologics Co was registered and established on Sept. 5, 2007, with Tsai as its chairperson and the fund took three seats of the seven that made up the company’s board of directorates.
On April 28 2009, Yu Chang Biologics Co changed its name to TaiMed Biologics Co (中裕新藥股份有限公司) and was approved on June 18 last year to register its emerging stocks on the over-the-counter (OTC) board of listed companies.
The legislature’s Economics Committee, where the KMT holds a majority, late yesterday passed a resolution asking the fund to declassify within the week all classified materials concerning the investment in the TaiMed Biologics Co and send the files to the committee for review.
Article 14 Section 1 of the Civil Servant Services Act (公務員服務法) stipulates that civil servants are not allowed, within three years of their resignation, to hold the position of chairperson, supervisor or manager at any company with which they had dealings at any time five years prior to their resignation.
KMT Legislator Ting Shou-chung (丁守中) quoted media reports accusing Tsai of having deliberately sought to enrich herself during her tenure as vice premier by asking the fund to invest in a company of which she later became chairperson.
During the questioning, National Development Fund convener Christina Liu (劉憶如) declined to speculate as to whether Tsai violated the “revolving door” clause, saying she would let officials in charge of that section explain the matter.
In response to KMT allegation that by serving as a chairperson of TaiMed Biologics prior to being appointed DPP chairperson, Tsai violated the “revolving door” clause, DPP spokesperson Chen Chi-mai (陳其邁) said that Tsai did not violate the clause, according to a detailed explanation of the article in question by the Ministry of Civil Service and the Executive Yuan’s Rules and Regulations Commission in 1996 and 2008.
On the charge that Tsai received NT$100 million in profits from selling her shares in TaiMed Biologics Co, Chen said Tsai became chairperson of TaiMed Biologics Co at the invitation of scientists David Ho (何大一), Wong Chi-huey (翁啟惠) and Chen Lan-bo (陳良博), three months after she quit her position as vice premier.
Tsai was invited because she had experience negotiating with other organizations and it was hoped that her appointment would help in negotiations with Genentech on authorization for new HIV/AIDS medication. It was also hoped that Tsai would help raise funds within the nation and help promote the development of the biotech industry, Chen Chi-mai said.
It was to help the development of the biotech industry that Tsai agreed to become chairperson and she also helped out with fundraising for the company, Chen Chi-mai said, adding that it was only then that the Executive Yuan agreed to invest the remaining 40 percent of the funding through the fund.
“The KMT’s allegations that Tsai received NT$100 million for selling her shares is completely untrue,” Chen said.
He further questioned why the administration of President Ma Ying-jeou (馬英九) invested NT$137 million in TaiMed Biologics Co last year if the company was “shady.” After investing NT$400 million in the company, the government made a profit of NT$1 billion.
DPP caucus whip Tsai Huang-liang (蔡煌瑯) said he suspected the KMT caucus arranged for the Economics Committee to raise the issue of the TaiMed Biologics Co investment to undermine Tsai’s campaign efforts.
In response, KMT caucus whip Lin Yi-shih (林益世) said that no one could tell whether the fund’s investment in TaiMed Biologics Co was practical, adding the KMT sought only insight into the issue by making the data more transparent and available to the public.
“The DPP’s criticism that this is slander only goes to show it has skeletons in its closet,” Lin said.
Translated by Jake Chung, Staff Writer
RETHINK? The defense ministry and Navy Command Headquarters could take over the indigenous submarine project and change its production timeline, a source said Admiral Huang Shu-kuang’s (黃曙光) resignation as head of the Indigenous Submarine Program and as a member of the National Security Council could affect the production of submarines, a source said yesterday. Huang in a statement last night said he had decided to resign due to national security concerns while expressing the hope that it would put a stop to political wrangling that only undermines the advancement of the nation’s defense capabilities. Taiwan People’s Party Legislator Vivian Huang (黃珊珊) yesterday said that the admiral, her older brother, felt it was time for him to step down and that he had completed what he
Taiwan has experienced its most significant improvement in the QS World University Rankings by Subject, data provided on Sunday by international higher education analyst Quacquarelli Symonds (QS) showed. Compared with last year’s edition of the rankings, which measure academic excellence and influence, Taiwanese universities made great improvements in the H Index metric, which evaluates research productivity and its impact, with a notable 30 percent increase overall, QS said. Taiwanese universities also made notable progress in the Citations per Paper metric, which measures the impact of research, achieving a 13 percent increase. Taiwanese universities gained 10 percent in Academic Reputation, but declined 18 percent
CHINA REACTS: The patrol and reconnaissance plane ‘transited the Taiwan Strait in international airspace,’ the 7th Fleet said, while Taipei said it saw nothing unusual The US 7th Fleet yesterday said that a US Navy P-8A Poseidon flew through the Taiwan Strait, a day after US and Chinese defense heads held their first talks since November 2022 in an effort to reduce regional tensions. The patrol and reconnaissance plane “transited the Taiwan Strait in international airspace,” the 7th Fleet said in a news release. “By operating within the Taiwan Strait in accordance with international law, the United States upholds the navigational rights and freedoms of all nations.” In a separate statement, the Ministry of National Defense said that it monitored nearby waters and airspace as the aircraft
UNDER DISCUSSION: The combatant command would integrate fast attack boat and anti-ship missile groups to defend waters closest to the coastline, a source said The military could establish a new combatant command as early as 2026, which would be tasked with defending Taiwan’s territorial waters 24 nautical miles (44.4km) from the nation’s coastline, a source familiar with the matter said yesterday. The new command, which would fall under the Naval Command Headquarters, would be led by a vice admiral and integrate existing fast attack boat and anti-ship missile groups, along with the Naval Maritime Surveillance and Reconnaissance Command, said the source, who asked to remain anonymous. It could be launched by 2026, but details are being discussed and no final timetable has been announced, the source